| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $378K | +33.8% | +79.2% |
| Cost of Revenue | $323K | +62.7% | +78.2% |
| Gross Profit | $55K | -34.7% | +85.3% |
| R&D Expense | $8K | +33.3% | -25.9% |
| Operating Income | -$145K | -3.2% | +39.4% |
| Interest Expense | $117K | -22.1% | -23.4% |
| Net Income | -$1.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $83K | -7.5% | +62.2% |
| Accounts Receivable | $44K | +164.4% | +239.8% |
| Current Assets | $127K | +19.4% | +85.9% |
| Total Assets | $250K | -54.1% | -75.0% |
| Current Liabilities | $9.2M | +14.1% | +92.8% |
| Long-term Debt |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$480K | -171.5% | — |
| Investing Cash Flow | $348K | +248.6% | — |
| Financing Cash Flow | $176K | +38.3% | — |
| -376.9% |
| -239.3% |
| EPS (Basic) | -$0.01 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| $258K |
| — |
| — |
| Total Liabilities | $9.3M | +13.9% | +90.6% |
| Stockholders' Equity | -$9.1M | -18.8% | -333.1% |